Evidence map›Paper›PMID 27190333›Full record

ArticleNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2017

APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.

Derek K Ng, Catherine C Robertson, Robert P Woroniecki, Sophie Limou, Christopher E Gillies, Kimberly J Reidy, Cheryl A Winkler, Sangeeta Hingorani, Keisha L Gibson, Rebecca Hjorten and 9 more

Registry-linked trialOpen access · bronzeAbstract readComparative Study
In one paragraph

Article in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00327860 (Chronic Kidney Disease in Children Prospective Cohort Study), which is not on this map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00327860 recruitingnot on this map

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2003 to 2028Enrolled1,300ConditionsChronic Kidney Disease
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 69 citations in OpenAlex.

  1. Update on APOL1 and chronic kidney diseases in children.Pediatric nephrology (Berlin, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Nephrotic Syndrome in Children.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 1 country.

Derek K NgJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Catherine C RobertsonDivision of Pediatric Nephrology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Robert P WoronieckiStony Brook Children's Hospital, Stony Brook, NY, USA.
Sophie LimouBasic Research Laboratory, NCI, Leidos Biomedical Inc., Frederick National Lab, Frederick, MD, USA.
Christopher E GilliesDivision of Pediatric Nephrology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Kimberly J ReidyMontefiore Medical Center, Bronx, NY, USA.
Cheryl A WinklerBasic Research Laboratory, NCI, Leidos Biomedical Inc., Frederick National Lab, Frederick, MD, USA.
Sangeeta HingoraniUniversity of Washington School of Medicine, Seattle, WA, USA.
Keisha L GibsonUniversity of North Carolina, Chapel Hill, NC, USA.
Rebecca HjortenMontefiore Medical Center, Bronx, NY, USA.
Christine B SethnaCohen's Children's Medical Center, New Hyde Park, NY, USA.
Jeffrey B KoppNIDDK, NIH, Bethesda, MD, USA.
Marva Moxey-MimsDivision of Kidney, Urology, and Hematology, NIDDK, NIH, Bethesda, MD, USA.
Susan L FurthChildren's Hospital of Philadelphia, Philadelphia, PA, USA.
Bradley A WaradyChildren's Mercy Hospital, Kansas City, MO, USA.
Matthias KretzlerInternal Medicine-Nephrology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
John R SedorCase Western Reserve University, Cleveland, OH, USA.
Frederick J KaskelMontefiore Medical Center, Bronx, NY, USA.
Matthew G SampsonDivision of Pediatric Nephrology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
Montefiore Medical Center · USLeidos (United States) · USMichigan Medicine · USNational Institutes of Health · USUniversity of Michigan–Ann Arbor · USCase Western Reserve University · USChildren's Hospital of Philadelphia · USChildren's Mercy Hospital · USCohen Children's Medical Center · USJohns Hopkins University · USStony Brook Children's Hospital · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · US

Funding

Chronic Kidney Disease in Children Study (C-Kid)U01DK066174 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SUSAN L. FURTH · 2003 to 2026
$25.1M
CKiD Cardiovascular Testing Travel SupplementU01DK066143 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Bradley Alan Warady · 2003 to 2026
$24.2M
Training Program in Clinical & Translationa Research in Human Glomerular DiseaseU54DK083912 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GIPSON, DEBBIE S · 2009 to 2023
$20.3M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U01DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MUNOZ, ALVARO · 2003 to 2017
$17.9M
Focal Segmental Glomerulosclerosis: Genetics & MechanismsZIADK043308 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI KOPP, JEFFREY BURNETT · 2009 to 2024
$15.7M
Genetics of Renal Disease in African AmericansZIABC010022 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WINKLER, CHERYL · 2009 to 2022
$8.9M
Translational Neuroscience CoreU54HD079123 · NICHD · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI FATEMI, S. ALI, SCHLAGGAR, BRADLEY L · 2014 to 2019
$7.9M
DEVELOPMENTAL RENAL AND ELECTROLYTE PHYSIOLOGYT32DK007110 · NIDDK · YESHIVA UNIVERSITY · PI KASKEL, FREDERICK JEFFREY, MELAMED, MICHAL L · 1986 to 2021
$5.6M
Central Biochemistry Laboratory of the CKiD ConsortiumU01DK082194 · NIDDK · UNIVERSITY OF ROCHESTER · PI SCHWARTZ, GEORGE J · 2008 to 2017
$3.5M
APOL1 - associated nephropathy from human-derived, intrarenal perspectiveR01DK108805 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MATTHEW Gordon SAMPSON, Simone Sanna-Cherchi · 2016 to 2026
$3.4M
Kidney disease mechanisms associated with human genetic variationR01DK097836 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI BRUGGEMAN, LESLIE A, O'TOOLE, JOHN F. · 2014 to 2017
$2.0M
An Integrative Systems Genetics Approach to Nephrotic SyndromeK08DK100662 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SAMPSON, MATTHEW GORDON · 2013 to 2015
$460k
NICHD NIH HHS U54 HD079123NIDDK NIH HHS K08 DK100662NIDDK NIH HHS R01 DK097836NIDDK NIH HHS R01 DK108805NIDDK NIH HHS T32 DK007110NIDDK NIH HHS U01 DK066116NIDDK NIH HHS U01 DK066143NIDDK NIH HHS U01 DK066174NIDDK NIH HHS U01 DK082194NIDDK NIH HHS U54 DK083912
6 · The paper itself

Abstract

backgroundIndividuals of African ancestry harboring two variant alleles within apolipoprotein L1 ( APOL1 ) are classified with a high-risk (HR) genotype. Adults with an HR genotype have increased risk of focal segmental glomerulosclerosis and chronic kidney disease compared with those with a low-risk (LR) genotype (0 or 1 variants). The role of APOL1 risk genotypes in children with glomerular disease is less well known.

methodsThis study characterized 104 African-American children with a glomerular disease by APOL1 genotype in two cohorts: the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE).

resultsAmong these subjects, 46% had an HR genotype with a similar age at cohort enrollment. For APOL1 HR children, the median age of disease onset was older (CKiD: 4.5 versus 11.5 years for LR versus HR; NEPTUNE: 11 versus 14 years for LR versus HR, respectively) and preterm birth was more common [CKiD: 27 versus 4%; NEPTUNE: 26 versus 12%; combined odds ratio 4.6 (95% confidence interval: 1.4, 15.5)]. Within studies, HR children had lower initial estimated glomerular filtration rate (eGFR) (CKiD: 53 versus 69 mL/min/1.73 m 2 ; NEPTUNE: 74 versus 94 mL/min/1.73 m 2 ). Longitudinal eGFR decline was faster among HR children versus LR (CKiD: -18 versus -8% per year; NEPTUNE: -13 versus -3% per year).

conclusionsChildren with an HR genotype in CKiD and NEPTUNE seem to have a more aggressive form of glomerular disease, in part due to a higher prevalence of focal segmental glomerulosclerosis. These consistent findings across independent cohorts suggest a common natural history for children with APOL1 -associated glomerular disease. Further study is needed to determine the generalizability of these findings.

Indexed as

AdolescentAge of OnsetApolipoprotein L1Black or African AmericanChildChild, PreschoolFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMaleNephrotic SyndromePolymorphism, Single NucleotideProspective StudiesUnited StatesAPOL1 protein, humanApolipoprotein L1APOL1epidemiologyFSGSnephrotic syndromepediatrics

Identifiers

PMID27190333
PMCPMC5837652
OpenAlexW2343659229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.